410
Views
4
CrossRef citations to date
0
Altmetric
ARTICLE

An Evidence-Based Systematic Review of Bitter Orange (Citrus aurantium) by the Natural Standard Research Collaboration

, PharmD, , BA,BS, , MS, , , , PhD, , PharmDc, , PharmD, , PharmD, , PharmD, , BA & , MPH show all
Pages 391-431 | Published online: 15 Nov 2013

REFERENCES

  • Akhlaghi M, Shabanian G, Rafieian-Kopaei M, Parvin N, Saadat M, Akhlaghi M. Citrus aurantium blossom and preoperative anxiety. Rev Bras Anestesiol. 2011;61(6):702–712.
  • Allison DB, Cutter G, Poehlman ET, Moore DR, Barnes S. Exactly which synephrine alkaloids does Citrus aurantium (bitter orange) contain? Int J Obes. (Lond). 2005;29(4):443–446.
  • Arbo MD, Schmitt GC, Limberger MF, Charao MF, Moro AM, Ribeiro GL, Dallegrave E, Garcia SC, Leal MB, Limberger RP. Subchronic toxicity of Citrus aurantium L. (Rutaceae) extract and p-synephrine in mice. Regul Toxicol Pharmacol. 2009;54(2):114–117.
  • Bent S, Padula A, Neuhaus J. Safety and efficacy of citrus aurantium for weight loss. Am J Cardiol. 2004;94(10):1359–1361.
  • Blanck HM, Serdula MK, Gillespie C, Galuska DA, Sharpe PA, Conway JM, Khan LK, Ainsworth BE. Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc. 2007;107(3):441–447.
  • Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine Expanded Commission E Monographs. 2000.
  • Bouchard NC, Howland MA, Greller HA, Hoffman RS, Nelson LS. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine. Mayo Clin Proc. 2005;80(4):541–545.
  • Brown CM, McGrath JC, Midgley JM, Muir AG, O'Brien JW, Thonoor CM, Williams CM, Wilson VG. Activities of octopamine and synephrine stereoisomers on alpha-adrenoceptors. Br J Pharmacol. 1988;93(2):417–429.
  • Buckle J. Use of aromatherapy as a complementary treatment for chronic pain. Altern.Ther Health Med. 1999;5(5):42–51.
  • Bui LT, Nguyen DT, Ambrose PJ. Blood pressure and heart rate effects following a single dose of bitter orange. Ann Pharmacother. 2006;40(1):53–57.
  • Burke J, Seda G, Allen D, Knee TS. A case of severe exercise-induced rhabdomyolysis associated with a weight-loss dietary supplement. Mil Med. 2007;172(6):656–658.
  • Calapai G, Firenzuoli F, Saitta A, Squadrito FR, Arlotta M, Costantino G, Inferrera G. Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat: a preliminary report. Fitoterapia. 1999;70(6):586–592.
  • Campbell-Tofte JI, Molgaard P, Josefsen K, Abdallah Z, Hansen SH, Cornett C, Mu H, Richter EA, Petersen HW, Norregaard JC, Winther K. Randomized and double-blinded pilot clinical study of the safety and anti-diabetic efficacy of the Rauvolfia-Citrus tea, as used in Nigerian traditional medicine. J Ethnopharmacol. 2011;133(2):402–411.
  • Carnat A, Carnat AP, Fraisse D, Lamaison JL. [Standardization of the sour orange flower and leaf]. Ann Pharm Fr. 1999;57(5):410–414.
  • Caron MF, Hotsko AL, Robertson S, Mandybur L, Kluger J, White CM. Electrocardiographic and hemodynamic effects of Panax ginseng. Ann Pharmacother. 2002;36(5):758–763.
  • Carvalho-Freitas MI, Costa M. Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L. Biol Pharm Bull. 2002;25(12):1629–1633.
  • Cervellati R, Renzulli C, Guerra MC, Speroni E. Evaluation of antioxidant activity of some natural polyphenolic compounds using the Briggs-Rauscher reaction method. J Agric Food Chem. 2002;50(26):7504–7509.
  • Cherniack EP. Potential applications for alternative medicine to treat obesity in an aging population. Altern Med Rev. 2008;13(1):34–42.
  • Clauson KA, Shields KM, McQueen CE, Persad N. Safety issues associated with commercially available energy drinks. J Am Pharm Assoc. (2003) 2008;48(3):e55-e63.
  • Cohen PA, Ernst E. Safety of herbal supplements: a guide for cardiologists. Cardiovasc Ther. 2010;28(4):246–253.
  • Colker C, Kalman D, Torina G. Effects of Citrus aurantium extract, caffeine, St. John's Wort on body fat loss, lipid levels, and mood states in overweight healthy adults. Curr Ther Res. 1999;60:145–153.
  • Di Marco MP, Edwards DJ, Wainer IW, Ducharme MP. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein. Life Sci. 2002;71(10):1149–1160.
  • Dragull K, Breksa AP, III, Cain B. Synephrine content of juice from Satsuma mandarins (Citrus unshiu Marcovitch). J Agric Food Chem. 2008;56(19):8874–8878.
  • Edwards DJ, Fitzsimmons ME, Schuetz EG, Yasuda K, Ducharme MP, Warbasse LH, Woster PM, Schuetz JD, Watkins P. 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther. 1999;65(3):237–244.
  • Fang F, Dong M, Zhu H. Effect of Citrus aurantium extract on L-type calcium currents in ventricular myocytes of single guinea pigs. Hunan Yi Ke Da Xue Xue Bao. 2003;28(4):353–356.
  • Farkas D, Greenblatt DJ. Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies. Expert Opin Drug Metab Toxicol. 2008;4(4):381–393.
  • Firenzuoli F, Gori L, Galapai C. Adverse reaction to an adrenergic herbal extract (Citrus aurantium). Phytomedicine. 2005;12(3):247–248.
  • Fugh-Berman A, Myers A. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exp Biol Med (Maywood). 2004;229(8):698–704.
  • Gange CA, Madias C, Felix-Getzik EM, Weintraub AR, Estes NA, III. Variant angina associated with bitter orange in a dietary supplement. Mayo Clin Proc. 2006;81(4):545–548.
  • Gougeon R, Harrigan K, Tremblay JF, Hedrei P, Lamarche M, Morais JA. Increase in the thermic effect of food in women by adrenergic amines extracted from citrus aurantium. Obes Res. 2005;13(7):1187–1194.
  • Gray S, Woolf AD. Citrus aurantium used for weight loss by an adolescent with anorexia nervosa. J Adolesc Health. 2005;37(5):414–415.
  • Gray SG, Clair AA. Influence of aromatherapy on medication administration to residential-care residents with dementia and behavioral challenges. Am J Alzheimers Dis Other Demen. 2002;17(3):169–174.
  • Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Carrier J, Khan IA, Edwards DJ, Shah A. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto. Clin Pharmacol Ther. 2004;76(5):428–440.
  • Haaz S, Fontaine KR, Cutter G, Limdi N, Perumean-Chaney S, Allison DB. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes Rev. 2006;7(1):79–88.
  • Haller CA, Benowitz NL, Jacob P, III. Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med. 2005;118(9):998–1003.
  • Haller CA, Duan M, Jacob P, III, Benowitz N. Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions. Br J Clin Pharmacol. 2008;65(6):833–840.
  • Hansen DK, George NI, White GE, Abdel-Rahman A, Pellicore LS, Fabricant D. Cardiovascular toxicity of Citrus aurantium in exercised rats. Cardiovasc Toxicol. 2013 Sep;13(3):208–219.
  • Hansen DK, George NI, White GE, Pellicore LS, Abdel-Rahman A, Fabricant D. Physiological effects following administration of Citrus aurantium for 28 days in rats. Toxicol Appl Pharmacol 2012;261(3):236–247.
  • Hansen DK, Juliar BE, White GE, Pellicore LS. Developmental toxicity of Citrus aurantium in rats. Birth Defects Res B Dev Reprod Toxicol. 2011;92(3):216–223.
  • Hata T, Sakaguchi I, Mori M, Ikeda N, Kato Y, Minamino M, Watabe K. Induction of apoptosis by Citrus paradisi essential oil in human leukemic (HL-60) cells. In Vivo. 2003;17(6):553–559.
  • Hernandez L, Munoz RA, Miro G, Martinez M, Silva-Parra J, Chavez PI. Use of medicinal plants by ambulatory patients in Puerto Rico. Am J Hosp Pharm. 1984;41(10):2060–2064.
  • Higgins JP, Tuttle TD, Higgins CL. Energy beverages: content and safety. Mayo Clin Proc. 2010;85(11):1033–1041.
  • Hosseinimehr SJ, Karami M. Citrus extract modulates genotoxicity induced by cyclophosphamide in mice bone marrow cells. J Pharm Pharmacol. 2005;57(4):505–509.
  • Hosseinimehr SJ, Tavakoli H, Pourheidari G, Sobhani A, Shafiee A. Radioprotective effects of citrus extract against gamma-irradiation in mouse bone marrow cells. J Radiat Res (Tokyo). 2003;44(3):237–241.
  • Hou YC, Hsiu SL, Yen HF, Chen CC, Chao PD. Effect of honey on naringin absorption from a decoction of the pericarps of Citrus grandis. Planta Med. 2000;66(5):439–443.
  • Hu JF. Inhibitory effects of Phyllanthus emblica juice on formation of N-nitrosomorpholine in vitro and N-nitrosoproline in rat and human. Zhonghua Yu Fang Yi Xue Za Zhi. 1990;24(3):132–135.
  • Huang YT, Wang GF, Chen CF, Chen CC, Hong CY, Yang MC. Fructus aurantii reduced portal pressure in portal hypertensive rats. Life Sci. 1995;57(22):2011–2020.
  • Ishiwa J, Sato T, Mimaki Y, Sashida Y, Yano M, Ito A. A citrus flavonoid, nobiletin, suppresses production and gene expression of matrix metalloproteinase 9/gelatinase B in rabbit synovial fibroblasts. J Rheumatol. 2000;27(1):20–25.
  • Jalili J, Askeroglu U, Alleyne B, Guyuron B. Herbal products that may contribute to hypertension. Plast Reconstr Surg. 2013;131(1):168–173.
  • Jordan R, Midgley JM, Thonoor CM, Williams CM. Beta-adrenergic activities of octopamine and synephrine stereoisomers on guinea-pig atria and trachea. J Pharm Pharmacol. 1987;39:752–754.
  • Jordan S, Murty M, Pilon K. Products containing bitter orange or synephrine: suspected cardiovascular adverse reactions. CMAJ. 2004;171(8):993–994.
  • Kaats GR, Miller H, Preuss HG, Stohs SJ. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract. Food Chem Toxicol. 2013;55:358–362.
  • Kaddu S, Kerl H, Wolf P. Accidental bullous phototoxic reactions to bergamot aromatherapy oil. J Am Acad Dermatol. 2001;45(3):458–461.
  • Keogh AM, Baron DW. Sympathomimetic abuse and coronary artery spasm. Br Med J. 1985;291:940.
  • Kim DH, Song MJ, Bae EA, Han MJ. Inhibitory effect of herbal medicines on rotavirus infectivity. Biol Pharm Bull. 2000;23(3):356–358.
  • Kim KW, Kim HD, Jung JS, Woo RS, Kim HS, Suh HW, Kim YH, Song DK. Characterization of antidepressant-like effects of p-synephrine stereoisomers. Naunyn Schmiedebergs Arch Pharmacol. 2001;364(1):21–26.
  • Lynch B. Review of the safety of p-synephrine and caffeine. Intertek-Cantox Report. 2013;1–20.
  • Malhotra S, Bailey DG, Paine MF, Watkins PB. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin Pharmacol Ther. 2001;69(1):14–23.
  • Martin KW, Ernst E. Herbal medicines for treatment of fungal infections: a systematic review of controlled clinical trials. Mycoses. 2004;47(3–4):87–92.
  • McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA. 2004;291(2):216–221.
  • McGuffin M. Media spins numbers on bitter orange AERs based on erroneous information from FDA. Herbal Gram. 2006;69:52–55.
  • Min B, Cios D, Kluger J, White CM. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects. Pharmacotherapy. 2005;25(12):1719–1724.
  • Miyazawa M, Okuno Y, Fukuyama M, Nakamura S, Kosaka H. Antimutagenic activity of polymethoxyflavonoids from Citrus aurantium. J Agric Food Chem. 1999;47(12):5239–5244.
  • Mwaiko GL. Citrus peel oil extracts as mosquito larvae insecticides. East Afr Med J. 1992;69(4):223–226.
  • Naganuma M, Hirose S, Nakayama Y, Nakajima K, Someya T. A study of the phototoxicity of lemon oil. Arch Dermatol Res. 1985;278(1):31–36.
  • Nasir JM, Durning SJ, Ferguson M, Barold HS, Haigney MC. Exercise-induced syncope associated with QT prolongation and ephedra-free Xenadrine. Mayo Clin Proc. 2004;79(8):1059–1062.
  • Nykamp DL, Fackih MN, Compton AL. Possible association of acute lateral-wall myocardial infarction and bitter orange supplement. Ann Pharmacother. 2004;38(5):812–816.
  • Pellati F, Benvenuti S. Chromatographic and electrophoretic methods for the analysis of phenethylamine [corrected] alkaloids in Citrus aurantium. J Chromatogr A. 2007;1161(1–2):71–88.
  • Pellati F, Benvenuti S, Melegari M, Firenzuoli F. Determination of adrenergic agonists from extracts and herbal products of Citrus aurantium L. var. amara by LC. J Pharm Biomed Anal. 2002;29(6):1113–1119.
  • Penzak SR, Acosta EP, Turner M, Edwards DJ, Hon YY, Desai HD, Jann MW. Effect of Seville orange juice and grapefruit juice on indinavir pharmacokinetics. J Clin Pharmacol. 2002;42(10):1165–1170.
  • Penzak SR, Jann MW, Cold JA, Hon YY, Desai HD, Gurley BJ. Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults. J Clin Pharmacol. 2001;41(10):1059–1063.
  • Preuss HG, DiFerdinando D, Bagchi M, Bagchi D. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview. J Med. 2002;33(1–4):247–264.
  • Ramadan W, Mourad B, Ibrahim S, Sonbol F. Oil of bitter orange: new topical antifungal agent. Int J Dermatol. 1996;35(6):448–449.
  • Rasmussen CB, Glisson JK, Minor DS. Dietary supplements and hypertension: potential benefits and precautions. J Clin Hypertens (Greenwich). 2012;14(7):467–471.
  • Reiter M, Brandt W. Relaxant effects on tracheal and ileal smooth muscles of the guinea pig. Arzneimittelforschung. 1985;35(1A):408–414.
  • Satoh Y, Tashiro S, Satoh M, Fujimoto Y, Xu JY, Ikekawa T. Studies on the bioactive constituents of aurantii fructus immaturus. Yakugaku Zasshi. 1996;116(3):244–250.
  • Seifert JG, Nelson A, Devonish J, Burke ER, Stohs SJ. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans. Int J Med Sci. 2011;8(3):192–197.
  • Setzer WN. Essential oils and anxiolytic aromatherapy. Nat Prod Commun. 2009;4(9):1305–1316.
  • Shara M, Stohs SJ. Safety evaluation of bitter orange extract (p-synephrine) in healthy volunteers. J Amer Coll Nutr. 2011;30:358.
  • Song DK, Suh HW, Jung JS, Wie MB, Son KH, Kim YH. Antidepressant-like effects of p-synephrine in mouse models of immobility tests. Neurosci Lett. 1996;214(2–3):107–110.
  • Stohs SJ. Assessment of the adverse event reports associated with Citrus aurantium (Bitter orange) from April 2004 to October 2009. J Funct Foods. 2011;2:235–238.
  • Stohs SJ, Preuss HG. Stereochemical and pharmacological differences between naturally occurring p-synephrine and synthetic p-synephrine. J Funct Foods. 2011.
  • Stohs SJ, Preuss HG. The safety of bitter orange (Citrus aurantium) and its primary protoalkaloid p-synephrine. Herbal Gram. 2011;89:34–39.
  • Stohs SJ, Preuss HG, Keith SC, Keith PL, Miller H, Kaats GR. Effects of p-synephrine alone and in combination with selected bioflavonoids on resting metabolism, blood pressure, heart rate and self-reported mood changes. Int J Med Sci. 2011;8(4):295–301.
  • Stohs SJ, Preuss HG, Shara M. A review of the receptor-binding properties of p-synephrine as related to its pharmacological effects. Oxid Med Cell Longev. 2011;2011:482973.
  • Stohs SJ, Preuss HG, Shara M. The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine. Phytother Res. 2011;25(10):1421–1428.
  • Stohs SJ, Preuss HG, Shara M. A review of the human clinical studies involving Citrus aurantium (bitter orange) extract and its primary protoalkaloid p-synephrine. Int J Med Sci. 2012;9(7):527–538.
  • Sultan S, Spector J, Mitchell RM. Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement. Mayo Clin Proc. 2006;81(12):1630–1631.
  • Suzuki O, Katsumata Y, Oya M, Matsumoto T. Oxidation of phenylethanolamine and octopamine by type A and type B monoamine oxidase. Effect of substrate concentration. Biochem Pharmacol. 1979;28(15):2327–2332.
  • Thomas JE, Munir JA, McIntyre PZ, Ferguson MA. STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature. Tex Heart Inst J 2009;36(6):586–590.
  • Uckoo RM, Jayaprakasha GK, Nelson SD, Patil BS. Rapid simultaneous determination of amines and organic acids in citrus using high-performance liquid chromatography. Talanta. 2011;83(3):948–954.
  • Visentin V, Morin N, Fontana E, Prevot D, Boucher J, Castan I, Valet P, Grujic D, Carpene C. Dual action of octopamine on glucose transport into adipocytes: inhibition via beta3-adrenoceptor activation and stimulation via oxidation by amine oxidases. J Pharmacol Exp Ther. 2001;299(1):96–104.
  • Vitetta L, Thomsen M, Sali A. Black cohosh and other herbal remedies associated with acute hepatitis. Med J Aust. 2003;178(8):411–412.
  • Wason S, DiGiacinto JL, Davis MW. Effects of grapefruit and Seville orange juices on the pharmacokinetic properties of colchicine in healthy subjects. Clin Ther. 2012;34(10):2161–2173.
  • Wosu LO. Management of clinical cases of peste des petits ruminants (PPR) disease in goats. Beitr Trop Landwirtsch Veterinarmed. 1989;27(3):357–361.
  • Wu H, Jing Z, Tang X, Wang X, Zhang S, Yu Y, Wang Z, Cao H, Huang L, Yu Y, Wang Y. To compare the efficacy of two kinds of Zhizhu pills in the treatment of functional dyspepsia of spleen-deficiency and qi-stagnation syndrome: a randomized group sequential comparative trial. BMC. Gastroenterol. 2011;11:81.
  • Xu L, Jiang J, Du FZ. Application of dannang recipe no. 2 in the perioperative stage of laparoscopic cholecystectomy. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28(12):1090–1092.
  • Zhou J, Qu F, Sang X, Burrows E, Nan R. Auricular acupressure may improve absorption of flavanones in the extracts from Citrus aurantium L. in the human body. J Altern Complement Med. 2008;14(4):423–425.
  • Zhou L, Hao R, Jiang L. Clinical study on retarding aging effect of tongbu recipe to traditional Chinese medicine. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999;19(4):218–220.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.